ATP and cancer immunosurveillance

O Kepp, L Bezu, T Yamazaki, F Di Virgilio… - The EMBO …, 2021 - embopress.org
While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic
metabolism of all the cellular compartments that form the tumor microenvironment (TME) …

Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy

M Jiang, J Zeng, L Zhao, M Zhang, J Ma, X Guan… - Nanoscale, 2021 - pubs.rsc.org
Chemotherapy has been a conventional paradigm for cancer treatment, and multifarious
chemotherapeutic drugs have been widely employed for decades with significant …

Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling

W Zhang, M Gong, W Zhang, J Mo, S Zhang… - Cell Death & …, 2022 - nature.com
Ferroptosis is a new form of regulated cell death that is mediated by intracellular iron and
ester oxygenase, and glutathione-dependent lipid hydroperoxidase glutathione peroxidase …

HMGB1 in the interplay between autophagy and apoptosis in cancer

R Chen, J Zou, X Zhong, J Li, R Kang, D Tang - Cancer Letters, 2024 - Elsevier
Lysosome-mediated autophagy and caspase-dependent apoptosis are dynamic processes
that maintain cellular homeostasis, ensuring cell health and functionality. The intricate …

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review

J Zhai, X Gu, Y Liu, Y Hu, Y Jiang… - Frontiers in …, 2023 - frontiersin.org
As traditional strategies for cancer treatment, some chemotherapy agents, such as
doxorubicin, oxaliplatin, cyclophosphamide, bortezomib, and paclitaxel exert their anti-tumor …

[HTML][HTML] Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better

M Zheng - Journal for immunotherapy of cancer, 2022 - ncbi.nlm.nih.gov
Background Recently, the US Food and Drug Administration (FDA) has approved immune
checkpoint blockade (ICB) for treating cancer patients with tumor mutation burden (TMB)> …

Autophagy in health and disease: From molecular mechanisms to therapeutic target

G Lu, Y Wang, Y Shi, Z Zhang, C Huang, W He… - MedComm, 2022 - Wiley Online Library
Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …

Immunogenic cell death (ICD) enhancers—Drugs that enhance the perception of ICD by dendritic cells

P Liu, L Zhao, L Zitvogel, O Kepp… - Immunological …, 2024 - Wiley Online Library
The search for immunostimulatory drugs applicable to cancer immunotherapy may profit
from target‐agnostic methods in which agents are screened for their functional impact on …

Engineering oxaliplatin prodrug nanoparticles for second near‐infrared fluorescence imaging‐guided immunotherapy of colorectal cancer

Q Zhu, F Sun, T Li, M Zhou, J Ye, A Ji, H Wang, C Ding… - Small, 2021 - Wiley Online Library
Colorectal cancer (CRC) ranks as the third common and the fourth lethal cancer type
worldwide. Immune checkpoint blockade therapy demonstrates great efficacy in a subset of …

[HTML][HTML] IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms

Q Wu, AL Tian, B Li, M Leduc, S Forveille… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Pharmacological autophagy enhancement constitutes a preclinically validated
strategy for preventing or treating most major age-associated diseases. Driven by this …